251 related articles for article (PubMed ID: 29120809)
41. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
[TBL] [Abstract][Full Text] [Related]
42. Optimization of Thymoquinone-Loaded Coconut Oil Nanostructured Lipid Carriers for the Management of Ethanol-Induced Ulcer.
Fahmy UA; L Alaofi A; Awan ZA; Alqarni HM; Alhakamy NA
AAPS PharmSciTech; 2020 May; 21(5):137. PubMed ID: 32419124
[TBL] [Abstract][Full Text] [Related]
43. Nanostructured Lipid Carrier of Propofol: a Promising Alternative to Marketed Soybean Oil-Based Nanoemulsion.
Shevalkar G; Pai R; Vavia P
AAPS PharmSciTech; 2019 May; 20(5):201. PubMed ID: 31139968
[TBL] [Abstract][Full Text] [Related]
44. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax.
Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F
Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527
[TBL] [Abstract][Full Text] [Related]
45. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
46. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
[TBL] [Abstract][Full Text] [Related]
47. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
48. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
49. Solid lipid dispersions: potential delivery system for functional ingredients in foods.
Asumadu-Mensah A; Smith KW; Ribeiro HS
J Food Sci; 2013 Jul; 78(7):E1000-8. PubMed ID: 23865449
[TBL] [Abstract][Full Text] [Related]
50. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
51. Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability.
Pan Y; Tikekar RV; Nitin N
Int J Pharm; 2016 Sep; 511(1):322-330. PubMed ID: 27418566
[TBL] [Abstract][Full Text] [Related]
52. Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers.
Vanka R; Kuppusamy G; Praveen Kumar S; Baruah UK; Karri VVSR; Pandey V; Babu PP
J Microencapsul; 2018 Mar; 35(2):121-136. PubMed ID: 29448884
[TBL] [Abstract][Full Text] [Related]
53. Fabrication of Mupirocin-Loaded Nanostructured Lipid Carrier and Its
Singh AP; Sharma SK; Gaur PK; Gupta DK
Assay Drug Dev Technol; 2021; 19(4):216-225. PubMed ID: 33781090
[No Abstract] [Full Text] [Related]
54. Multiple Response Optimization of Beeswax-Based Nanostructured Lipid Carriers for the Controlled Release of Vitamin E.
Souza IDL; Saez V; Campos VEB; Nascimento MR; Mansur CRE
J Nanosci Nanotechnol; 2020 Jan; 20(1):31-41. PubMed ID: 31383137
[TBL] [Abstract][Full Text] [Related]
55. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
56. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
57. Preparation of Salicylic Acid Loaded Nanostructured Lipid Carriers Using Box-Behnken Design: Optimization, Characterization and Physicochemical Stability.
Pantub K; Wongtrakul P; Janwitayanuchit W
J Oleo Sci; 2017; 66(12):1311-1319. PubMed ID: 29199206
[TBL] [Abstract][Full Text] [Related]
58. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
Safwat S; Ishak RAH; Hathout RM; Mortada ND
Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
[TBL] [Abstract][Full Text] [Related]
59. Effect of Oil Content on Physiochemical Characteristics of γ-Oryzanol-Loaded Nanostructured Lipid Carriers.
Pornputtapitak W; Pantakitcharoenkul J; Teeranachaideekul V; Sinthiptharakoon K; Sapcharoenkun C; Meemuk B
J Oleo Sci; 2019 Aug; 68(8):699-707. PubMed ID: 31292337
[TBL] [Abstract][Full Text] [Related]
60. Nanostructured lipid carriers as a delivery system of biochanin A.
Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
